Benefit of interferon β-1a on MSFC progression in secondary progressive MS

2002403 citationsJournal Article

Authors

IFNbeta-1a demonstrated benefit on MSFC progression, relapses, quality of life, and MRI activity in SPMS.

Responsible consumption and production

Published in: Neurology

Volume 59, Issue 5, pp. 679-687

Field-Weighted Citation Impact: 11.49